New protein and PCR markers RAK for diagnosis, prognosis and surgery guidance for breast cancer.

[1]  Austin Rm,et al.  Stereotactic core biopsy of nonpalpable breast lesions. , 1995 .

[2]  N. Sneige,et al.  Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results. , 1995, Human pathology.

[3]  A. Rosenberg,et al.  Ten‐year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy , 1995, Cancer.

[4]  D. Page,et al.  Controversies in the local management of invasive and non-invasive breast cancer. , 1995, Cancer letters.

[5]  D. Mcintosh,et al.  Nuclear antigens with epitopic homology to the cell surface antigens : the neglected determinants of malignant transformation , 1995 .

[6]  D. Mcintosh,et al.  ANTIGEN RAK : A NEW BREAST CANCER DIAGNOSTIC MARKER , 1995 .

[7]  D. Mcintosh,et al.  Mechanisms of cancer growth promotion by HIV-I neutralizing antibodies , 1995 .

[8]  Liu Et,et al.  Developing strategies for intervention and prevention in hereditary breast cancer. , 1995 .

[9]  M. Stefanek.  Bilateral prophylactic mastectomy: issues and concerns. , 1995, Journal of the National Cancer Institute. Monographs.

[10]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[11]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[12]  R. Nowak.  Breast cancer gene offers surprises. , 1994, Science.

[13]  G. Fagerberg,et al.  Recurrence-free survival in patients with small breast cancer. An analysis of cancers 10 mm or less detected clinically and by screening. , 1994, The European journal of surgery = Acta chirurgica.

[14]  D. Schultz,et al.  The importance of mammographic screening relative to the treatment of women with carcinoma of the breast. , 1994, Archives of internal medicine.

[15]  R. Senie,et al.  Method of tumor detection influences disease‐free survival of women with breast carcinoma , 1994, Cancer.

[16]  L. Garfinkel,et al.  Changing trends: An overview of breast cancer incidence and mortality , 1994, Cancer.

[17]  D. Mcintosh,et al.  Novel Family of Gynecologic Cancer Antigens Detected by Anti-HIV Antibody , 1994, Infectious diseases in obstetrics and gynecology.

[18]  E. Rakowicz-Szulczyńska.  Nuclear Localization of Growth Factors and of Monoclonal Antibodies , 1993 .

[19]  M. King,et al.  Inherited breast and ovarian cancer. What are the risks? What are the choices? , 1993, JAMA.

[20]  F. Collins,et al.  Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. , 1993, JAMA.

[21]  G. Colditz,et al.  A prospective study of benign breast disease and the risk of breast cancer , 1992, JAMA.

[22]  A. Giuliano,et al.  The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions. , 1991, AJR. American journal of roentgenology.

[23]  P. Taylor,et al.  A prospective study of the development of breast cancer in 16,692 women with benign breast disease. , 1988, American journal of epidemiology.

[24]  M. King,et al.  Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[25]  David L. Page,et al.  Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study , 1985, Cancer.

[26]  W D Dupont,et al.  Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.

[27]  R. Hutter.  Goodbye to "fibrocystic disease". , 1985, The New England journal of medicine.

[28]  R. Gold,et al.  SIGNIFICANCE OF MARGINATION OF BENIGN AND MALIGNANT INFILTRATIVE MAMMARY LESIONS: ROENTGENOGRAPHIC-PATHOLOGICAL CORRELATION , 1973 .

[29]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.